Início › Câncer de Pulmão de Não Pequenas Células › Virgínia

Ensaios clínicos de Câncer de Pulmão de Não Pequenas Células em Virgínia

137 estudos para Câncer de Pulmão de Não Pequenas Células estão buscando participantes em locais em Virgínia.

Cidades em Virgínia

Texto oficial do estudo (Inglês)

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Ballad Health Cancer Care - Bristol, Bristol
Augusta Health Center for Cancer and Blood Disorders, Fishersville
Centra Alan B Pearson Regional Cancer Center, Lynchburg
e mais 7

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT04267848

A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)

Virginia Cancer Specialists ( Site 0167), Fairfax
Virginia Oncology Associates (VOA) ( Site 8101), Norfolk
VCU Health Adult Outpatient Pavillion ( Site 0193), Richmond

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT06623422

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Virginia Cancer Specialists, Fairfax

RecrutandoFase 1/2

Idades 12 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT04585750

A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.

Blue Ridge Cancer Center, Blacksburg
Virginia Cancer Specialists, PC, Fairfax
Shenandoah Oncology P.C., Winchester

RecrutandoFase 2/3

Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT07365319

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

Inova Schar Cancer Institute, Fairfax
NEXT Virginia, Fairfax

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT06270706

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

Exelixis Clinical Site #66, Charlottesville

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT05176483

A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)

Hematology Oncology Associates of Fredericksburg ( Site 3275), Fredericksburg

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT07513376

A Clinical Trial of Calderasib (MK-1084) and Durvalumab in People With Non-Small Cell Lung Cancer (MK-1084-015/KANDLELIT-015)

Virginia Cancer Specialists ( Site 0114), Fairfax

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT07554339

A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)

Hematology Oncology Associates of Fredericksburg ( Site 9550), Fredericksburg
Blue Ridge Cancer Care ( Site 0144), Roanoke

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT07190248

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Hematology Oncology Associates of Fredericksburg Inc, Fredericksburg
Centra Alan B Pearson Regional Cancer Center, Lynchburg
Virginia Cancer Institute, Richmond
e mais 1

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT06498635

A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors

ALX Center 2, Fairfax

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 30 de set. de 2026 · NCT07085091

A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)

Blue Ridge Cancer Care, Christiansburg
Virginia Oncology Associates, Norfolk

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 30 de set. de 2026 · NCT07361497

A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors

Site 04, Fairfax

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 30 de set. de 2026 · NCT07814248

A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)

Local Institution - 0337, Richmond
Shenandoah Oncology, P.C., Winchester

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 30 de set. de 2026 · NCT07361510

A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Non-Small Cell Lung Cancer

University of Virginia, Charlottesville
Virginia Cancer Specialists, Fairfax

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 30 de set. de 2026 · NCT07659782

Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC

Virginia Cancer Specialists, Fairfax

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 30 de set. de 2026 · NCT06765109

Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations

Virgnia Cancer Specialists /ID# 269633, Leesburg

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 29 de set. de 2026 · NCT06772623

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

Virginia Cancer Specialists, Fairfax

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 29 de set. de 2026 · NCT06881784

A Study of PHN-012 in Patients With Advanced Solid Tumors

PHN-012-001 Site, Fairfax

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 29 de set. de 2026 · NCT07127874

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

Oncology & Hematology Associates of Southwest Virginia,Inc.DBA Blue Ridge Cancer Care, Blacksburg
Oncology & Hematology Associates of Southwest Virginia, Inc., DBA Blue Ridge Cancer care| Emmett Medical & Surgical Center, Low Moor
VCU Emergency Center at New Kent, Quinton
e mais 12

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT07144280

A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer

Virginia Cancer Specialists, Fairfax

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT05498428

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

UVA Comprehensive Cancer Center, Charlottesville
UVA Health Fontaine Research Park, Charlottesville
University of Virginia, Charlottesville
e mais 1

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT07222566

A Study of Amivantamab and Olomorasib Combination Therapy in Participants With Metastatic Non-Small Cell Lung Cancer

Virginia Cancer Specialists, Fairfax

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT07227025

A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Virginia Cancer Specialists, Fairfax

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT06667076

Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers

VCU Medical Center Gateway Building, Richmond
Virginia Commonwealth University, Richmond
VCU Health Stony Point, Richmond
e mais 4

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT07227298

Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

University of Virginia Health System, Charlottesville
VCU Health Adult Outpatient Pavillion, Richmond

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 24 de set. de 2026 · NCT06890598

Pan-tumor MRD Study

Virginia Cancer Institute, Richmond

RecrutandoEstudo observacional

Idades 18 e acima · Todos os sexos · Atualizado em 24 de set. de 2026 · NCT06605404

Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change

University of Virginia Cancer Center, Charlottesville

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 24 de set. de 2026 · NCT03191149

Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations

Research Site, Fort Belvoir
Research Site, Leesburg
Research Site, Midlothian
e mais 1

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 23 de set. de 2026 · NCT06357533

A Study of Gilteritinib in Adults With Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC)

Virginia Cancer Specialists PC, Fairfax

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 23 de set. de 2026 · NCT07140016

Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer

Research Site, Fairfax

RecrutandoFase 2

Idades de 18 a 95 · Todos os sexos · Atualizado em 23 de set. de 2026 · NCT05061550

Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer

Virginia Cancer Specialists - Arlington, Arlington
Virginia Cancer Specialists, Fairfax
VCU Massey Cancer Center, Richmond
e mais 1

RecrutandoFase 2/3

Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT06712316

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

NEXT Oncology Virginia, Fairfax

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT06128551

A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Virginia Cancer Specialists - Fairfax /ID# 272004, Fairfax

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT06568939

A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

Inova Schar Cancer Institute Clinical Trials, Fairfax

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07488676

Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)

University of Virginia Health System, Charlottesville
Virginia Commonwealth University (Vcu), Richmond

RecrutandoFase 2/3

Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07100080

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

Virginia Cancer Specialists, Fairfax

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 21 de set. de 2026 · NCT05983432

A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations

Next Oncology Virginia Cancer Specialist, Fairfax

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 21 de set. de 2026 · NCT07629960

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

Research Site, Fairfax
Research Site, Fredericksburg

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 18 de set. de 2026 · NCT06692738

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1

Clinical Study Site, Blacksburg
Clinical Study Site, Charlottesville
Clinical Study Site, Fairfax
e mais 2

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 18 de set. de 2026 · NCT06767514

Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.